This finding linked higher MCP-1 levels with an early propensity to scar following glaucoma filtration surgery, identifying it as a possible tear biomarker to predict the potential level of post-operative scarring and thus the risk of surgical failure in patients [3,8]. This evidence concerns the gene CCL2 and glaucoma.